Tag Archives: EVIO Biosciences

EVIO Biosciences Launches the World’s First Genomics Testing Program for Pathogen Identification in Cannabis

EVIO Inc., (OTCQB: EVIO), a leading North American provider of cannabis testing and scientific research for the regulated cannabis industry, is excited to announce EVIO Biosciences launches the release of the first Genomics Testing program for Pathogen Identification in Cannabis.

EVIO Inc. Co-Founder, CEO and Chairman, William Waldrop Discusses Company Updates with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

Some key issues are how we can consolidate in a market that’s beginning to mature. EVIO Labs acquired MRX Labs, an award-winning lab in Tigard, Oregon. By combining the EVIO Labs Portland location to the Tigard location, they’ll be able to save over $300,000 per year on the bottom line.

As you have probably seen from the flurry of press releases over the last few months, the EVIO team has been hard at work expanding our footprint. With the reporting of our current quarter results we believe that now is an ideal time to provide you with an update on EVIO's recent developments and milestones.

EVIO Inc. Launches EVIO Biosciences Division to Support Cannabinoid Research

The division's goals encompass emerging health benefits and advanced delivery modes for cannabinoids and cannabis products to the human endocannabinoid system.